ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 109 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,409 | -74.4% | 435,575 | -1.0% | 0.00% | – |
| Q2 2023 | $224,415 | -19.2% | 440,030 | -0.2% | 0.00% | – |
| Q1 2023 | $277,854 | +0.6% | 441,037 | +3.6% | 0.00% | – |
| Q4 2022 | $276,209 | -62.4% | 425,525 | -0.3% | 0.00% | – |
| Q3 2022 | $734,000 | +37.5% | 426,592 | -0.9% | 0.00% | – |
| Q2 2022 | $534,000 | -62.1% | 430,304 | -80.1% | 0.00% | – |
| Q1 2022 | $1,408,000 | -44.7% | 2,160,095 | -7.5% | 0.00% | – |
| Q4 2021 | $2,545,000 | -35.4% | 2,335,083 | +7.8% | 0.00% | -100.0% |
| Q3 2021 | $3,942,000 | -35.0% | 2,166,139 | -5.7% | 0.00% | 0.0% |
| Q2 2021 | $6,064,000 | -29.0% | 2,296,437 | -3.2% | 0.00% | -50.0% |
| Q1 2021 | $8,542,000 | +37.7% | 2,372,416 | -3.6% | 0.00% | +100.0% |
| Q4 2020 | $6,203,000 | -6.3% | 2,461,343 | -6.3% | 0.00% | 0.0% |
| Q3 2020 | $6,623,000 | -26.1% | 2,627,997 | -3.8% | 0.00% | -50.0% |
| Q2 2020 | $8,959,000 | +53.5% | 2,731,339 | +14.7% | 0.00% | 0.0% |
| Q1 2020 | $5,836,000 | -40.6% | 2,382,045 | +14.3% | 0.00% | 0.0% |
| Q4 2019 | $9,833,000 | +12.4% | 2,083,188 | +2.0% | 0.00% | 0.0% |
| Q3 2019 | $8,746,000 | -12.6% | 2,043,338 | +19.1% | 0.00% | 0.0% |
| Q2 2019 | $10,007,000 | +56.0% | 1,716,285 | +3.0% | 0.00% | 0.0% |
| Q1 2019 | $6,415,000 | +108.2% | 1,666,346 | +1.1% | 0.00% | +100.0% |
| Q4 2018 | $3,081,000 | -41.3% | 1,647,754 | +0.5% | 0.00% | 0.0% |
| Q3 2018 | $5,247,000 | +7.0% | 1,639,686 | +1.0% | 0.00% | 0.0% |
| Q2 2018 | $4,902,000 | -20.9% | 1,623,297 | +2.7% | 0.00% | -50.0% |
| Q1 2018 | $6,195,000 | -4.7% | 1,580,392 | +0.6% | 0.00% | 0.0% |
| Q4 2017 | $6,502,000 | -34.7% | 1,570,714 | -3.1% | 0.00% | -33.3% |
| Q3 2017 | $9,957,000 | -1.8% | 1,621,776 | -0.6% | 0.00% | 0.0% |
| Q2 2017 | $10,144,000 | +8.0% | 1,630,858 | +10.1% | 0.00% | 0.0% |
| Q1 2017 | $9,394,000 | +24.0% | 1,481,791 | +4.6% | 0.00% | +50.0% |
| Q4 2016 | $7,576,000 | -3.6% | 1,416,193 | +1.4% | 0.00% | 0.0% |
| Q3 2016 | $7,860,000 | -0.4% | 1,396,094 | -2.9% | 0.00% | -33.3% |
| Q2 2016 | $7,890,000 | -22.8% | 1,437,273 | +4.4% | 0.00% | 0.0% |
| Q1 2016 | $10,217,000 | -10.2% | 1,376,916 | +0.6% | 0.00% | -25.0% |
| Q4 2015 | $11,376,000 | -1.0% | 1,369,007 | +7.4% | 0.00% | 0.0% |
| Q3 2015 | $11,487,000 | -13.1% | 1,274,916 | +15.7% | 0.00% | 0.0% |
| Q2 2015 | $13,226,000 | +18.6% | 1,102,212 | +6.4% | 0.00% | +33.3% |
| Q1 2015 | $11,152,000 | +145.4% | 1,035,508 | +15.5% | 0.00% | +200.0% |
| Q4 2014 | $4,545,000 | +85.5% | 896,396 | -3.4% | 0.00% | 0.0% |
| Q3 2014 | $2,450,000 | -35.9% | 928,099 | -2.1% | 0.00% | 0.0% |
| Q2 2014 | $3,821,000 | -22.7% | 948,188 | -12.2% | 0.00% | -50.0% |
| Q1 2014 | $4,944,000 | +2.4% | 1,079,369 | -2.9% | 0.00% | 0.0% |
| Q4 2013 | $4,827,000 | +29.3% | 1,112,105 | +17.4% | 0.00% | +100.0% |
| Q3 2013 | $3,732,000 | +87.2% | 947,232 | +0.2% | 0.00% | 0.0% |
| Q2 2013 | $1,994,000 | – | 944,985 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |